BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6246212)

  • 1. Antigen-induced suppression of experimental allergic neuritis in the guinea pig.
    McDermott JR; Keith AB
    J Neurol Sci; 1980 Apr; 46(1):137-43. PubMed ID: 6246212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental allergic neuritis with P2 protein of PNS myelin.
    McDermott JR; Keith AB
    Z Naturforsch C Biosci; 1979 Aug; 34(7-8):641-3. PubMed ID: 91275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuritogenicity and encephalitogenicity of P2 in the rat, guinea-pig and rabbit.
    Kadlubowski M; Hughes RA
    J Neurol Sci; 1980 Nov; 48(2):171-8. PubMed ID: 6159457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat. II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN.
    Jung S; Gaupp S; Hartung HP; Toyka KV
    J Neuroimmunol; 2001 May; 116(1):21-8. PubMed ID: 11311326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological comparative studies on experimental allergic neuritis (EAN) induced in rabbits by P2 protein-ganglioside complexes.
    Takeda S; Ikuta F; Nagai Y
    Jpn J Exp Med; 1980 Dec; 50(6):453-62. PubMed ID: 6168787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental allergic neuritis in the Lewis rat.
    Smith ME; Forno LS; Hofmann WW
    J Neuropathol Exp Neurol; 1979 Jul; 38(4):377-91. PubMed ID: 312920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis.
    Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Toyka KV; Hartung HP
    J Neurol Sci; 1993 Jul; 117(1-2):197-205. PubMed ID: 7691994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
    Jung S; Toyka K; Hartung HP
    Brain; 1996 Aug; 119 ( Pt 4)():1079-90. PubMed ID: 8813272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental allergic neuritis. I. Rat strain differences in the response to bovine myelin antigens.
    Hoffman PM; Powers JM; Weise MJ; Brostoff SW
    Brain Res; 1980 Aug; 195(2):355-62. PubMed ID: 6249443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuritogenic activity of peripheral nerve myelin proteins in Lewis rats.
    Suzuki M; Kitamura K; Uyemura K; Ogawa Y; Ishihara Y; Matsuyama H
    Neurosci Lett; 1980 Oct; 19(3):353-8. PubMed ID: 6189030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2 protein-induced experimental allergic neuritis. An ultrastructural study.
    Saida K; Saida T; Pleasure DE; Nishitani H
    J Neurol Sci; 1983 Dec; 62(1-3):77-93. PubMed ID: 6199467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental allergic neuritis. Humoral and cellular immune responses to the cyanogen bromide peptides of the P2 protein.
    Milek DJ; Cunningham JM; Powers JM; Brostoff SW
    J Neuroimmunol; 1983 Apr; 4(2):105-16. PubMed ID: 6187769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1.
    Zhu J; Link H; Weerth S; Linington C; Mix E; Qiao J
    J Neurol Sci; 1994 Sep; 125(2):132-7. PubMed ID: 7528788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic experimental allergic neuritis (EAN) in juvenile guinea pigs: immunological comparison with acute EAN in adult guinea pigs.
    Suzumura A; Sobue G; Sugimura K; Matsuoka Y; Sobue I
    Acta Neurol Scand; 1985 May; 71(5):364-72. PubMed ID: 4013660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of acute and chronic experimental allergic encephalomyelitis in Strain 13 guinea pigs. A clinical and pathological study.
    Raine CS; Snyder DH; Stone SH; Bornstein MB
    J Neurol Sci; 1977 Apr; 31(3):355-67. PubMed ID: 845617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.